thiazoles has been researched along with Psoriasis in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (11.76) | 18.7374 |
1990's | 1 (5.88) | 18.2507 |
2000's | 4 (23.53) | 29.6817 |
2010's | 9 (52.94) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Buckley, DA; Soriano, LF | 1 |
Reddy, SP; Wu, JJ | 1 |
D'Ambrosio, D; Dingemanse, J; Krause, A | 1 |
Armstrong, AW; Singh, S | 1 |
González, MA; Hospital, M; Martinez-Mera, C; Turrión-Merino, L | 1 |
Menter, A; Ryan, C | 1 |
Arenberger, P; Burcklen, M; Chimenti, S; D'Ambrosio, D; Holló, P; Sator, PG; Stefani, M; Vaclavkova, A | 1 |
Warren, RB; Yiu, ZZ | 1 |
Anderson, RJ; Cunningham, A; Donaldson, M; George, SE; Groundwater, PW | 1 |
Alshorafa, AK; Chen, M; Guo, Q; Tan, G; Tang, Z; Yin, R; Zeng, F | 1 |
Kuenzli, S; Saurat, JH | 1 |
Hussar, DA | 1 |
An, L; Bao, Y; Hou, S; Lin, J; Lin, X; Liu, X | 1 |
Kozak, S; Michałowski, R; Olejnicka, Z; Urban, J | 1 |
Amin, NM; Benjamin, E; Finnegan, J; Pershadsingh, HA; Sproul, JA | 1 |
Benson, SC; Chi, Y; Ellis, CN; Fisher, GJ; Kurtz, TW; Pershadsingh, HA; Varani, J; Zeigler, ME | 1 |
Fayolle, J; Thiers, H | 1 |
2 review(s) available for thiazoles and Psoriasis
Article | Year |
---|---|
Oral small molecules for psoriasis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Humans; Patient Selection; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Thalidomide; Thiazoles | 2018 |
Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Antagonists; Administration, Oral; Arthritis, Psoriatic; Azetidines; Biological Factors; Biological Therapy; Clinical Trials as Topic; Humans; Isonicotinic Acids; Janus Kinases; Niacinamide; Phosphodiesterase 4 Inhibitors; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Receptors, Lysosphingolipid; rho-Associated Kinases; Sulfonamides; Thalidomide; Thiazoles | 2016 |
4 trial(s) available for thiazoles and Psoriasis
Article | Year |
---|---|
Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis.
Topics: Clinical Trials, Phase III as Topic; Computer Simulation; Dose-Response Relationship, Drug; Humans; Lymphocyte Count; Models, Biological; Patient Selection; Placebos; Psoriasis; Receptors, Lysosphingolipid; Severity of Illness Index; Thiazoles; Treatment Outcome | 2018 |
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial.
Topics: Administration, Oral; Chronic Disease; Double-Blind Method; Humans; Psoriasis; Thiazoles; Treatment Outcome | 2014 |
Effect of topical PPARbeta/delta and PPARgamma agonists on plaque psoriasis. A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Pilot Projects; Psoriasis; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sulfides; Thiazoles; Thiazolidinediones; Transcription Factors; Treatment Outcome; Vasodilator Agents | 2003 |
Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.
Topics: Adult; Animals; Antineoplastic Agents; Cell Differentiation; Chromans; DNA Primers; Female; Humans; Keratinocytes; Ligands; Male; Mice; Mice, SCID; Psoriasis; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Diseases; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2000 |
11 other study(ies) available for thiazoles and Psoriasis
Article | Year |
---|---|
Unrecognized leather sofa dermatitis complicating chronic plaque psoriasis.
Topics: Adult; Dermatitis, Allergic Contact; Humans; Interior Design and Furnishings; Patch Tests; Psoriasis; Thiazoles | 2021 |
Oral ponesimod for psoriasis compared to other investigational therapies.
Topics: Biological Factors; Humans; Psoriasis; Severity of Illness Index; Therapies, Investigational; Thiazoles | 2016 |
Isothiazolinones in paint as a cause of airborne contact dermatitis in a patient with psoriasis receiving anti-interleukin-17 therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Dermatitis, Allergic Contact; Dermatologic Agents; Disinfectants; Facial Dermatoses; Humans; Male; Paint; Patch Tests; Psoriasis; Thiazoles | 2019 |
Ponesimod--a future oral therapy for psoriasis?
Topics: Humans; Psoriasis; Thiazoles | 2014 |
Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay.
Topics: Anthralin; Anti-Infective Agents, Local; Caspase 3; Caspase 7; Cell Line; Cell Proliferation; Colorimetry; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluorescent Dyes; Fluorometry; Humans; Keratinocytes; Methotrexate; Psoriasis; Reproducibility of Results; Tetrazolium Salts; Thiazoles; Thymidine | 2010 |
Psoriasis is associated with low serum levels of hydrogen sulfide, a potential anti-inflammatory molecule.
Topics: Anti-Inflammatory Agents; Blotting, Western; Cell Line; DNA Primers; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Hydrogen Sulfide; Interleukin-6; Interleukin-8; Keratinocytes; Nitric Oxide; Nitrites; Psoriasis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2012 |
New drugs 04, part 1.
Topics: Adalimumab; Alefacept; alpha-Galactosidase; Anisoles; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antioxidants; Antiprotozoal Agents; Antirheumatic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Drug Approval; Drug Therapy; Fabry Disease; Gefitinib; Humans; Iduronidase; Indoles; Isoenzymes; Lentigo; Lung Neoplasms; Migraine Disorders; Mucopolysaccharidosis I; Nitro Compounds; Patient Education as Topic; Propylamines; Psoriasis; Pyrrolidines; Quinazolines; Recombinant Fusion Proteins; Serotonin Receptor Agonists; Thiazoles; Tryptamines | 2004 |
Effects of isocamptothecin, a novel camptothecin analogue, on proliferation, apoptosis and telomerase activity in HaCaT cells.
Topics: Analysis of Variance; Apoptosis; Camptotheca; Camptothecin; Cell Line; Cell Proliferation; DNA; Down-Regulation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Growth Inhibitors; Humans; Isomerism; Keratinocytes; Polymerase Chain Reaction; Psoriasis; Telomerase; Tetrazolium Salts; Thiazoles | 2008 |
Studies on the therapeutic effect of Wratizolin in selected dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Child; Child, Preschool; Dermatitis, Atopic; Female; Herpes Simplex; Herpes Zoster; Humans; Male; Middle Aged; Molluscum Contagiosum; Psoriasis; Pyoderma; Skin Diseases; Skin Diseases, Infectious; Thiazoles; Warts | 1983 |
Treatment of psoriasis with troglitazone therapy.
Topics: Adult; Aged; Chromans; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Middle Aged; Platelet Aggregation Inhibitors; Psoriasis; Thiazoles; Thiazolidinediones; Troglitazone | 1998 |
[Thiazolidine carboxylic acid (TCA) in dermatology].
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Carboxylic Acids; Child; Dermatitis, Seborrheic; Female; Humans; Male; Middle Aged; Psoriasis; Thiazoles | 1972 |